STERIS plc

STE Healthcare Medical Devices

STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.

Revenue
+8.79%
EPS
+12.8%
Free cash flow
+43.6%
Total debt
−0.21%

Quarter to September 2026, against a year earlier

251.44 2.68 −1.05%
Market cap
$24.8B
P/E
30.0×
Fwd P/E
25.1×
Dividend yield
1.02%
F-score
9/9
Altman Z
5.10
Beneish M
−2.68
Dividend safety
86/100

STERIS plc 8-K/A filed Aug 6, 2026

Period ended May 7, 2026 · Filed · accepted 4:20 PM ET · Document on sec.gov · Filing index

5.02 Departure or appointment of directors or officers

Nothing in this filing raised a red flag. The items it reports are listed above; the document itself is on sec.gov.

Read the filing on sec.gov